133 related articles for article (PubMed ID: 34637881)
1. Antiproliferative effects of metformin in cellular models of pheochromocytoma.
Meireles CG; Lourenço de Lima C; Martins de Paula Oliveira M; Abe da Rocha Miranda R; Romano L; Yo-Stella Brashaw T; Neves da Silva Guerra E; de Assis Rocha Neves F; Chapple JP; Simeoni LA; Lofrano-Porto A
Mol Cell Endocrinol; 2022 Jan; 539():111484. PubMed ID: 34637881
[TBL] [Abstract][Full Text] [Related]
2. PDK1 Inhibitor GSK-470 Exhibits Potent Anticancer Activity in a Pheochromocytoma PC12 Cell Tumor Model via Akt/mTOR Pathway.
Zhang X; Zhong S
Anticancer Agents Med Chem; 2020; 20(7):828-833. PubMed ID: 32188393
[TBL] [Abstract][Full Text] [Related]
3. Targeting PI3K/mTOR signaling exerts potent antitumor activity in pheochromocytoma in vivo.
Lee M; Minaskan N; Wiedemann T; Irmler M; Beckers J; Yousefi BH; Kaissis G; Braren R; Laitinen I; Pellegata NS
Endocr Relat Cancer; 2017 Jan; 24(1):1-15. PubMed ID: 27811202
[TBL] [Abstract][Full Text] [Related]
4. Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing mTOR/AKT signaling.
Lu CC; Chiang JH; Tsai FJ; Hsu YM; Juan YN; Yang JS; Chiu HY
Int J Oncol; 2019 Apr; 54(4):1271-1281. PubMed ID: 30720062
[TBL] [Abstract][Full Text] [Related]
5. Metformin Suppresses Proliferation and Viability of Rat Pheochromocytoma Cells.
Li M; Jiang X; Su T; Jiang L; Zhou W; Wang W
Med Sci Monit; 2017 Jul; 23():3253-3260. PubMed ID: 28675758
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytoma.
Leinhäuser I; Richter A; Lee M; Höfig I; Anastasov N; Fend F; Ercolino T; Mannelli M; Gimenez-Roqueplo AP; Robledo M; de Krijger R; Beuschlein F; Atkinson MJ; Pellegata NS
Oncotarget; 2015 Nov; 6(36):39111-26. PubMed ID: 26337467
[TBL] [Abstract][Full Text] [Related]
7. The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma.
Peng S; Zhang J; Tan X; Huang Y; Xu J; Silk N; Zhang D; Liu Q; Jiang J
Front Endocrinol (Lausanne); 2020; 11():586857. PubMed ID: 33329393
[TBL] [Abstract][Full Text] [Related]
8. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
Li C; Liu VW; Chan DW; Yao KM; Ngan HY
Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
[TBL] [Abstract][Full Text] [Related]
9. Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma.
Korpershoek E; Petri BJ; van Nederveen FH; Dinjens WN; Verhofstad AA; de Herder WW; Schmid S; Perren A; Komminoth P; de Krijger RR
Endocr Relat Cancer; 2007 Jun; 14(2):453-62. PubMed ID: 17639058
[TBL] [Abstract][Full Text] [Related]
10. Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells.
Klubo-Gwiezdzinska J; Jensen K; Costello J; Patel A; Hoperia V; Bauer A; Burman KD; Wartofsky L; Vasko V
Endocr Relat Cancer; 2012 Jun; 19(3):447-56. PubMed ID: 22389381
[TBL] [Abstract][Full Text] [Related]
11. Seven Novel Genes Related to Cell Proliferation and Migration of VHL-Mutated Pheochromocytoma.
Gao S; Liu L; Li Z; Pang Y; Shi J; Zhu F
Front Endocrinol (Lausanne); 2021; 12():598656. PubMed ID: 33828526
[TBL] [Abstract][Full Text] [Related]
12. Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience.
Korpershoek E; Van Nederveen FH; Dannenberg H; Petri BJ; Komminoth P; Perren A; Lenders JW; Verhofstad AA; De Herder WW; De Krijger RR; Dinjens WN
Ann N Y Acad Sci; 2006 Aug; 1073():138-48. PubMed ID: 17102080
[TBL] [Abstract][Full Text] [Related]
13. Secretin receptor promotes the proliferation of endocrine tumor cells via the PI3K/AKT pathway.
Lee M; Waser B; Reubi JC; Pellegata NS
Mol Endocrinol; 2012 Aug; 26(8):1394-405. PubMed ID: 22692904
[TBL] [Abstract][Full Text] [Related]
14. Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.
Pollard PJ; El-Bahrawy M; Poulsom R; Elia G; Killick P; Kelly G; Hunt T; Jeffery R; Seedhar P; Barwell J; Latif F; Gleeson MJ; Hodgson SV; Stamp GW; Tomlinson IP; Maher ER
J Clin Endocrinol Metab; 2006 Nov; 91(11):4593-8. PubMed ID: 16954163
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial respiration inhibitor enhances the anti-tumor effect of high-dose ascorbic acid in castration-resistant prostate cancer.
Qiu J; Yang T; Long Y; He P; Shen W; Zhang B; Shi X; Peng L; Li Z; Zhang X
J Mol Med (Berl); 2023 Feb; 101(1-2):125-138. PubMed ID: 36478125
[TBL] [Abstract][Full Text] [Related]
16. Anticancer effects of metformin on neuroendocrine tumor cells in vitro.
Vlotides G; Tanyeri A; Spampatti M; Zitzmann K; Chourdakis M; Spttl C; Maurer J; Nölting S; Göke B; Auernhammer CJ
Hormones (Athens); 2014; 13(4):498-508. PubMed ID: 25402373
[TBL] [Abstract][Full Text] [Related]
17. ErbB-2 induces bilateral adrenal pheochromocytoma formation in mice.
Lai EW; Rodriguez OC; Aventian M; Cromelin C; Fricke ST; Martiniova L; Lubensky IA; Lisanti MP; Picard KL; Powers JF; Tischler AS; Pacak K; Albanese C
Cell Cycle; 2007 Aug; 6(15):1946-50. PubMed ID: 17671425
[TBL] [Abstract][Full Text] [Related]
18. The VHL gene is epigenetically inactivated in pheochromocytomas and abdominal paragangliomas.
Andreasson A; Kiss NB; Caramuta S; Sulaiman L; Svahn F; Bäckdahl M; Höög A; Juhlin CC; Larsson C
Epigenetics; 2013 Dec; 8(12):1347-54. PubMed ID: 24149047
[TBL] [Abstract][Full Text] [Related]
19. EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance.
Li S; Rodriguez J; Li W; Bullova P; Fell SM; Surova O; Westerlund I; Topcic D; Bergsland M; Stenman A; Muhr J; Nistér M; Holmberg J; Juhlin CC; Larsson C; von Kriegsheim A; Kaelin WG; Schlisio S
Proc Natl Acad Sci U S A; 2019 Aug; 116(34):16997-17006. PubMed ID: 31375625
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations.
Pinato DJ; Ramachandran R; Toussi ST; Vergine M; Ngo N; Sharma R; Lloyd T; Meeran K; Palazzo F; Martin N; Khoo B; Dina R; Tan TM
Br J Cancer; 2013 Feb; 108(2):429-37. PubMed ID: 23257898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
